Have a personal or library account? Click to login
Transfusion-related acute lung injury in an era of TRALI risk mitigation Cover

Transfusion-related acute lung injury in an era of TRALI risk mitigation

By: J.C. Lavelle,  M.L. Grant and  J.K. Karp  
Paid access
|Oct 2019

Abstract

Transfusion-related acute lung injury (TRALI) is a rare complication of transfusion, for which the true incidence remains obscure, since there are a number of factors that may lead to misdiagnosis. Despite this, it continues to be the leading cause of transfusion-associated mortality. Here we present a historical case of TRALI in an elderly female who received group AB plasma and discuss how current mitigation strategies would likely have prevented its occurrence. It is important to remember that both immune and non-immune factors play a role in TRALI pathogenesis, and although current preventative strategies may decrease TRALI’s incidence, they likely will not eliminate it. Immunohematology2015;31:155–158.

DOI: https://doi.org/10.21307/immunohematology-2019-085 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 155 - 158
Published on: Oct 26, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:

© 2019 J.C. Lavelle, M.L. Grant, J.K. Karp, published by American National Red Cross
This work is licensed under the Creative Commons License.